SAS, UNC-Chapel Hill to Transform Antiviral Drug Development
SAS and the University of North Carolina at Chapel Hill (UNC-Chapel Hill) recently partnered to transform the antiviral drug development process and prevent infectious disease threats from turning into...Thermo Fisher Launches Enzyme Analyzers for Assay Applications
Thermo Fisher Scientific recently launched single, fully-automated enzyme analyzers designed specifically for enzyme assay applications. The Thermo Scientific Gallery Enzyme Master and Thermo...3 Use Cases for Real World Evidence in Pharma Drug Development
Real world evidence (RWE) in pharmaceutical drug development analyzes real world data, such as electronic health records and data from wearable devices, to complement clinical trials data. RWE...Premier, Top Health Systems Acquire Exela to Combat Drug Shortages
Premier and 11 top health systems recently acquired a minority stake in Exela Holdings, the holding company of Exela Pharma Sciences, to combat drug shortages in the US. Participating Premier...WHO Launches Next Trial Phase to Test COVID-19 Drugs in Patients
The World Health Organization (WHO) recently announced the next phase in its Solidarity trial, Solidarity PLUS, to test new COVID-19 drugs in hospitalized patients. The trial will enroll...NCQA Program Supports Best Practices in Specialty Pharmacy
NCQA recently launched Specialty Pharmacy Accreditation, a service to help discern quality leaders and support value-based contracting in specialty pharmacy. Specialty Pharmacy Accreditation...UIC Awarded $6M to Test COVID-19 Drug Candidate For Lung Damage
The Department of Defense (DoD) recently awarded a $6 million technology and therapeutic development award to the University of Illinois (UIC) to test a COVID-19 drug candidate. UIC will use the...Bristol Myers Squibb to Co-Develop Eisai’s Antibody Drug Conjugate
Bristol Myers Squibb and Japan-based pharmaceutical company, Eisai, recently entered into a global collaboration agreement for the co-development and co-commercialization of an antibody drug conjugate,...Understanding Basic Principles of Pharmaceutical Drug Discovery
Drug discovery is a crucial part of the drug development pipeline, beginning with the identification of a disease target to the creation of lead compounds. According to Amanda Garner, PhD, Associate...Prescribers Switch to Remdesivir for COVID-19 Treatment
Although COVID-19 treatments azithromycin and hydroxychloroquine were often used in patients early in the pandemic, use decreased significantly by the end of 2020. But for drugs such as remdesivir and...FDA Guidance Addresses Master Protocols for COVID-19 Drugs
FDA recently released guidance about evaluating COVID-19 drugs and biological products for the treatment or prevention of the coronavirus. In section A, the agency stated that all sponsors developing...COVID-19 Mortality Dropped as Drug Therapies Emerged
New COVID-19 drug therapies along with better clinical management of patients with SARS-CoV-2 infection may have contributed to reductions in in-hospital COVID-19 mortality rates, according to a recent...Sponsored by Pure Storage
